| Página Inicial | Commercial Aprovals  Vaccines Commercial Release of Genetically Modified Organism to be used as an Avian Vaccine - VECTORMUNE® HVT-IBD – Live frozen vaccine against Marek’s Disease and Gumboro Disease Commercial Release of Genetically Modified Organism to be used as an Avian Vaccine - VECTORMUNE® HVT-NDV – Live frozen vaccine against Marek’s Disease and Newcastle Disease Live lyophilized vaccine against Avian Pox Virus, Mycoplasma gallisepticum and Avian Encephalomyelitis - VECTORMUNE® FP-MG+AE Live lyophilized vaccine against Fowl Pox and Mycoplasma gallisepticum - VECTORMUNE® FP MG Live vaccine against Escherichia coli - Poulvac E. coli Inactivated vaccine against Porcine Circovirosis - Porcilis Circumvent PCV Inactivated vaccine against Porcine Circovirosis ¡V Ingelvac Circoflex Inactivated vaccine against Porcine Circovirosis - Suvaxyn PCV2 one Dose Production Marketing and Export of VAXXITEK Import of anti-tick vaccine | Topo | Imprimir |	MENU CTNBio CIBio Gestão Administrativa Legislações Legislation Documentos Aprovações Comerciais Commercial Aprovals Eventos Outros Links Listas de Discussão Orgãos de Fiscalização Fale Conosco
Copyright ©2006 CTNBio Setor Policial Sul -SPO Área 5 Quadra 3 Bloco B - Térreo Salas 10 à 14 CEP - 70610-200 BRASÍLIA - DF TEL: (61) 3411-5516 FAX: (61) 3317-7475 - Assessoria de Imprensa: (61) 3317-7515	ctnbio@mct.gov.br